There’s a lot to be optimistic about in the Financial sector as 2 analysts just weighed in on Deutsche Bank AG (DB – Research Report) and Pardes Biosciences (PRDS – Research Report) with bullish sentiments.
Deutsche Bank AG (DB)
J.P. Morgan analyst Kian Abouhossein maintained a Buy rating on Deutsche Bank AG today and set a price target of EUR16.00. The company’s shares closed last Thursday at $10.86.
According to TipRanks.com, Abouhossein is a 5-star analyst with an average return of
Currently, the analyst consensus on Deutsche Bank AG is a Moderate Buy with an average price target of $14.94, which is a 38.2% upside from current levels. In a report issued on March 3, Kepler Capital also upgraded the stock to Buy with a EUR15.50 price target.
See the top stocks recommended by analysts >>
Pardes Biosciences (PRDS)
Jefferies analyst Dennis Ding maintained a Buy rating on Pardes Biosciences yesterday and set a price target of $25.00. The company’s shares closed last Thursday at $6.44, close to its 52-week low of $5.54.
According to TipRanks.com, Ding is ranked #6535 out of 7798 analysts.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Pardes Biosciences with a $25.00 average price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on DB:
- Analysts Conflicted on These Consumer Goods Names: Constellation Brands (STZ) and Bayerische Motoren Werke Aktiengesellschaft (OtherBAMXF)
- Netflix Stock: Deep Value Near 52-Week Lows?
- ZIM Integrated Shipping Surges 6.3% on Stellar Q4 Beat & Dividends
- Alibaba Stock: Growth & Value Combined
- WISH Stock: Cheap Enough to Outweigh the Risks?
